HELI HUNTER: Open Payments
NPI 1790812477 · GOLDEN VALLEY, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 14 payments from 12 companies in 2025. Trend: 2023 $251 · 2024 $284 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 2 | $42 |
| GENZYME CORPORATION | 2 | $32 |
| ARGENX US, INC. | 1 | $21 |
| CSL Behring | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Octapharma USA, Inc. | 1 | $18 |
| Celgene Corporation | 1 | $16 |
| Alexion Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
Products named: TYSABRI, VYVGART HYTRULO, Haegarda, UPLIZNA, KESIMPTA, OCTAGAM IMMUNE GLOBULIN (HUMAN), ZEPOSIA, ULTOMIRIS.
Industry payments across MN — which companies pay providers there.
